Capital Advisory Group Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,221	Closed	-$134K	–	158
2022 Q2	$134K	Hold	1,221	–	–	0.08%	147
2022 Q1	$159K	Buy	+1,221	New	+$159K	0.07%	171
2021 Q4	–	Sell	-1,368	Closed	-$221K	–	308
2021 Q3	$221K	Hold	1,368	–	–	0.08%	188
2021 Q2	$224K	Hold	1,368	–	–	0.08%	191
2021 Q1	$206K	Buy	1,368 +133	+11%	+$21.1K	0.08%	181
2020 Q4	$187K	Hold	1,235	–	–	0.08%	191
2020 Q3	$167K	Sell	1,235 -15	-1%	-$2.04K	0.09%	149
2020 Q2	$171K	Sell	1,250 -109	-8%	-$13.9K	0.1%	146
2020 Q1	$147K	Buy	1,359 +15	+1%	+$1.73K	0.18%	70
2019 Q4	$161K	Buy	1,344 +390	+41%	+$43.5K	0.09%	111
2019 Q3	$95K	Sell	954 -21	-2%	-$2.2K	0.06%	114
2019 Q2	$107K	Hold	975	–	–	0.07%	111
2019 Q1	$108K	Sell	975 -313	-24%	-$34.3K	0.08%	103
2018 Q4	$124K	Sell	1,288 -33	-2%	-$3.5K	0.1%	94
2018 Q3	$161K	Hold	1,321	–	–	0.11%	90
2018 Q2	$145K	Sell	1,321 -4,076	-76%	-$436K	0.1%	86
2018 Q1	$577K	Buy	+5,397	New	+$598K	0.42%	38

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Capital Advisory Group Advisory Services's IBB Position: Q3 2022 in Review

Capital Advisory Group Advisory Services sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 1,221 shares — an estimated $134K sold.

Capital Advisory Group Advisory Services first reported a position in IBB in Q1 2018 and held it in 17 quarters. The position peaked at $577K in Q1 2018. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Capital Advisory Group Advisory Services reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 1,221 iShares Biotechnology ETF shares in Q3 2022, an estimated $134K.
Capital Advisory Group Advisory Services first reported a position in iShares Biotechnology ETF in Q1 2018 and held it in 17 quarters.
Capital Advisory Group Advisory Services's iShares Biotechnology ETF position peaked at $577K in Q1 2018.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q3 2022, filed 7 Nov 2022.